January 2022

Retired Armed Forces personnel till 2002 could avail medical facilities only for specific high cost surgery/treatment for a limited number of diseases covered under the Army Group Insurance(Medical Branch Scheme) (AGI(MBS)) and Armed Forces Group Insurance Scheme(Management Information System) (AFGIS (MIS)) schemes. These medicare schemes could provide some relief to the ESM, but it was not a comprehensive scheme as compared to and available for other Central Government Employees.

National Institute for Research in Tuberculosis [Formerly Tuberculosis Research Centre (TRC)], a permanent Institute under the Indian Council of Medical Research (ICMR), is an internationally recognized Institution for Tuberculosis (TB) research. It is a Supranational Reference Laboratory and a WHO Collaborating Centre for TB Research and Training. Recently, an International Centre for Excellence in Research (ICER) in collaboration with NIH was established at the Centre.

Centurion University is duly recognized as a pioneer is Skill Integrated Higher Education. Its unique model lays specific emphasis on creating sustainable livelihoods on a national scale in challenging geographies through education that results in employability and sparks entrepreneurship. This model has been recognized by multiple Governments (Central and State), International Organizations such as UNESCO and the World Bank as well as Policy Think-tanks such as the Niti Ayog.

Royal College of Pharmacy is one of the oldest among the various colleges of Chhattisgarh, as its stepping stone was placed in the year 2004. Our College was established by the society of Combined Academy of Technical Education, Raipur. This Society made it unique centre of excellence at all levels of Pharmaceutical Education under the leadership of Chairman. The institution has been approved by PCI, New Delhi and All India Council of Technical Education (AICTE) New Delhi (Formerly), Affliated from Chhattishgarh Swami Vivekanand Technical University, Bhilai.

Guru Nanak Institutions is one of the largest educational groups in India with 10,000 plus Students currently enrolled in various programs of studies including Engineering and Technology, Pharmacy, Business Management and Dental Science. Guru Nanak Institutions currently has 11 education centers spread across Hyderabad, Nagpur and Roorkee.

Post : Associate Professor

Maithri Drugs is one of India's fast-growing pharmaceutical companies. Maithri's strategic focus is on active pharma ingredients (APIs). The company is widely recognized for its excellent research & development and aggressive growth strategies. Our 32 US DMFs and 9 CEPs in a short span attest to our R&D excellence.

Post : Management Trainee's/ Junior Executive Trainee's / Executive Trainee's

Mankind Pharma, the 7th largest Pharmaceutical Company of India, was incepted in 1995 with a meagre capital of 50 lakhs and 20 employees. Today, we are amongst the top 5 fastest growing Pharmaceutical companies of India with an employee base of more than 10000 and heading towards a turnover of  INR 3000 crores.

Post : Sr. Officer / Executive / Sr. Executive (Sterile Injectable)

Aspiro Pharma is one of the fastest growing Injectable Pharmaceutical company in India fully dedicated to research, development and manufacturing of Generic Parenteral Formulations (Lyophilized and Liquid products in the form of injectables, Pre-filled Syringes (PFS) and IV Bags) that find therapeutic application in treating a wide range of ailments. Aspiro Pharma is one of the leading USFDA approved pharmaceutical company (one of the fastest growing pharmaceutical company with global outreach) .

Novartis announced that the U.S. Court of Appeals for the Federal Circuit (CAFC) issued its decision upholding the validity of US Patent No. 9,187,405 covering a dosing regimen for Gilenya. In August 2020, the U.S. Federal District Court for the District of Delaware issued a favorable decision in the Gilenya patent litigation and a permanent injunction was granted against HEC Pharma until the expiration of the ‘405 patent in December 2027 (including pediatric exclusivity).